Skip to main content
Top
Published in: Metabolic Brain Disease 2/2010

01-06-2010 | Original Paper

Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria

Authors: Nese Dericioglu, Serap Saygi

Published in: Metabolic Brain Disease | Issue 2/2010

Login to get access

Abstract

Phenylketonuria (PKU) is one of the most common inherited metabolic disorders, which is characterized by excessive accumulation of phenylalanine (Phe) in tissues. Generalized seizures occur in 25% of the patients. Little is known about seizures and their treatment in adult PKU patients, and information with newer antiepileptic drugs is lacking. Here we report an adult patient who developed generalized seizures later in life, despite strict dietary control, and whose seizures were aggravated by levetiracetam (LEV). Convulsions ceased after discontinuation of LEV and the patient has been seizure free on topiramate 125 mg/day.
Literature
go back to reference Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114–S120CrossRefPubMed Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114–S120CrossRefPubMed
go back to reference Gross PT, Berlow S, Schuett VET, Fariello RG (1981) EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes. Arch Neurol 38(2):122–126PubMed Gross PT, Berlow S, Schuett VET, Fariello RG (1981) EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes. Arch Neurol 38(2):122–126PubMed
go back to reference Lin CM, Thajeb P (2007) Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 22(1):105–109CrossRefPubMed Lin CM, Thajeb P (2007) Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 22(1):105–109CrossRefPubMed
go back to reference Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101(26):9861–9866CrossRefPubMed Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101(26):9861–9866CrossRefPubMed
go back to reference Martynyuk AE, Ucar DA, Yang DD, Norman WM, Carney PR, Dennis DM, Laipis PJ (2007) Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels. Epilepsia 48(6):1143–1150CrossRefPubMed Martynyuk AE, Ucar DA, Yang DD, Norman WM, Carney PR, Dennis DM, Laipis PJ (2007) Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels. Epilepsia 48(6):1143–1150CrossRefPubMed
go back to reference Szücs A, Clemens Z, Jakus R, Rasonyi G, Fabo D, Hollo A, Barcs G, Kelemen A, Janszky J (2008) The risk of paradoxical levetiracetam effect is increased in mentally retarded patients. Epilepsia 49(7):1174–1179CrossRefPubMed Szücs A, Clemens Z, Jakus R, Rasonyi G, Fabo D, Hollo A, Barcs G, Kelemen A, Janszky J (2008) The risk of paradoxical levetiracetam effect is increased in mentally retarded patients. Epilepsia 49(7):1174–1179CrossRefPubMed
go back to reference Thompson AJ, Tillotson S, Smith I, Kendall B, More SG, Brenton DP (1993) Brain MRI changes in phenylketonuria. Association with dietary status. Brain 116:811–821CrossRefPubMed Thompson AJ, Tillotson S, Smith I, Kendall B, More SG, Brenton DP (1993) Brain MRI changes in phenylketonuria. Association with dietary status. Brain 116:811–821CrossRefPubMed
go back to reference Villasana D, Butler IJ, Williams JC, Roongata SM (1989) Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 12:451–457CrossRefPubMed Villasana D, Butler IJ, Williams JC, Roongata SM (1989) Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 12:451–457CrossRefPubMed
go back to reference Walter JH, White F, Wraith JE, Jenkins JP, Wilson BP (1997) Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria. J Inherit Metab Dis 20:367–369CrossRefPubMed Walter JH, White F, Wraith JE, Jenkins JP, Wilson BP (1997) Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria. J Inherit Metab Dis 20:367–369CrossRefPubMed
go back to reference Williams RA, Mamotte CDS, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29:31–41PubMed Williams RA, Mamotte CDS, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29:31–41PubMed
go back to reference Zhang SX, Yu WM, Wang GZ (1995) An electroencephalogram analysis of 94 phenylketonuria patients. J Clin Electroencephalogr 4(3):139–141 Zhang SX, Yu WM, Wang GZ (1995) An electroencephalogram analysis of 94 phenylketonuria patients. J Clin Electroencephalogr 4(3):139–141
go back to reference Zhongshu Z, Weiming Y, Yukio F, Cheng L, Ning Z, Zhixing W (2001) Clinical analysis of West syndrome associated with phenylketonuria. Brain Dev 23:552–557CrossRefPubMed Zhongshu Z, Weiming Y, Yukio F, Cheng L, Ning Z, Zhixing W (2001) Clinical analysis of West syndrome associated with phenylketonuria. Brain Dev 23:552–557CrossRefPubMed
Metadata
Title
Generalized seizures aggravated by levetiracetam in an adult patient with phenylketonuria
Authors
Nese Dericioglu
Serap Saygi
Publication date
01-06-2010
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 2/2010
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-010-9197-7

Other articles of this Issue 2/2010

Metabolic Brain Disease 2/2010 Go to the issue